Trial Profile
Phase II Trial of Palliative Chemotherapy With TS-1 and Oxaliplatin for Patients With Advanced Hepatocellular Carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 05 Mar 2018 Status changed from recruiting to completed, according to results published in the BMC Cancer.
- 09 Sep 2011 New trial record